Public Health Weekly Report 2021; 14(53): 3768-3776
Published online December 30, 2021
© The Korea Disease Control and Prevention Agency
Hye Young Lee1, Ji Joo Lee1, Hanul Park1, Mi Yu1, Jong Mu Kim1, Sang-Eun Lee1, Young-Joon Park1, Moonsu Kim2, Seonggon Kim2, Hanna Yoo2, Mi Young Kim3, Jin Su Song3, Jihee Lee3, Jeong Hee Yu4, Eun-young Kim4, Hyo Seon Jeong4, Jae Hwa Chung4
1Central Disease Control Headquarters, Korea Centers for Disease Control and Prevention Agency (KDCA)
2Incheon Metropolitan Government, Incheon
3Capital Regional Center for Disease Control and Prevention, KDCA
4Honam Regional Center for Disease Control and Prevention, KDCA
On December 1, 2021, SARS-CoV-2 B.1.1.529 (Omicron) variant of concern (VOC) was identified for the first time in the Republic of Korea (ROK) and a total of 123 cases with Omicron VOC were identified through quarantine and community epidemiological surveys. As of December 12, 2021, among them, a total number of cases (123), 90 cases were confirmed through RT-PCR and NGS analysis and 33 epidemiological related cases were divided. By infection route, 23 imported cases and 100 additional cases of transmission in local communities were identified.
In term of ages, gender, and vaccination, 63.4% (78 cases) were between 20 and 59 years of age, 57.7% (71 cases) were female, which marked a slightly higher than male, and 54.5% (67 cases) were unvaccinated. Asymptomatic at diagnosis were 24.4% (30 cases), and the main symptoms of Omicron VOC were fever 32.5% (40 cases), sore throat 30.9% (38 cases), cough 29.3% (36 cases), headache 20.3% (25 cases). There were no cases exhibiting severe symptoms and no deaths up to now. The average incubation period was 4.2 days (2-8 days), and the serial interval was 2.8 to 3.4 days. As a result of the initial analysis of the epidemiological properties of the 123 cases of the omicron VOC, this report will share information with the public and related experts. This report recommended that the KDCA continuoue to monitor and respond to the omicron VOC.
Key words Coronavirus disease 2019, SARS-CoV-2, Omicron, Variant of Concern
| Characteristics | No. | % |
|---|---|---|
| Age group | ||
| <20 | 36 | 29.3 |
| 20-39 | 54 | 43.9 |
| 40-59 | 24 | 19.5 |
| ≥60 | 9 | 7.3 |
| Sex | ||
| Male | 52 | 42.3 |
| Female | 71 | 57.7 |
| International travel | 23 | 18.7 |
| COVID-19 vaccination statusa | ||
| Unvaccinated | 67 | 54.5 |
| Partially vaccinatedb | 7 | 5.7 |
| Vaccinated | 46 | 37.4 |
| Symptom profile | ||
| Asymptomatic | 30 | 24.4 |
| Symptomatic | 93 | 75.6 |
| Initial signs or symptoms | ||
| Fever | 40 | 32.5 |
| Chills | 19 | 15.4 |
| Cough | 36 | 29.3 |
| Sputum | 17 | 13.8 |
| Sore throat | 38 | 30.9 |
| Headache | 25 | 20.3 |
| Myalgia | 17 | 13.8 |
| Anosmia/Ageusia | 1 | 0.8 |
| Outcome | ||
| Severe Disease | - | |
| Death | - | |
a Vaccination history except unconfirmed 3 person
b A partially vaccinated person had received a COVID-19 vaccine but not completed the primary series ≥14 days before illness onset or receipt of a positive SARS-CoV-2 test result
Public Health Weekly Report 2021; 14(53): 3768-3776
Published online December 30, 2021
Copyright © The Korea Disease Control and Prevention Agency.
Hye Young Lee1, Ji Joo Lee1, Hanul Park1, Mi Yu1, Jong Mu Kim1, Sang-Eun Lee1, Young-Joon Park1, Moonsu Kim2, Seonggon Kim2, Hanna Yoo2, Mi Young Kim3, Jin Su Song3, Jihee Lee3, Jeong Hee Yu4, Eun-young Kim4, Hyo Seon Jeong4, Jae Hwa Chung4
1Central Disease Control Headquarters, Korea Centers for Disease Control and Prevention Agency (KDCA)
2Incheon Metropolitan Government, Incheon
3Capital Regional Center for Disease Control and Prevention, KDCA
4Honam Regional Center for Disease Control and Prevention, KDCA
On December 1, 2021, SARS-CoV-2 B.1.1.529 (Omicron) variant of concern (VOC) was identified for the first time in the Republic of Korea (ROK) and a total of 123 cases with Omicron VOC were identified through quarantine and community epidemiological surveys. As of December 12, 2021, among them, a total number of cases (123), 90 cases were confirmed through RT-PCR and NGS analysis and 33 epidemiological related cases were divided. By infection route, 23 imported cases and 100 additional cases of transmission in local communities were identified.
In term of ages, gender, and vaccination, 63.4% (78 cases) were between 20 and 59 years of age, 57.7% (71 cases) were female, which marked a slightly higher than male, and 54.5% (67 cases) were unvaccinated. Asymptomatic at diagnosis were 24.4% (30 cases), and the main symptoms of Omicron VOC were fever 32.5% (40 cases), sore throat 30.9% (38 cases), cough 29.3% (36 cases), headache 20.3% (25 cases). There were no cases exhibiting severe symptoms and no deaths up to now. The average incubation period was 4.2 days (2-8 days), and the serial interval was 2.8 to 3.4 days. As a result of the initial analysis of the epidemiological properties of the 123 cases of the omicron VOC, this report will share information with the public and related experts. This report recommended that the KDCA continuoue to monitor and respond to the omicron VOC.
Keywords: Coronavirus disease 2019, SARS-CoV-2, Omicron, Variant of Concern
| Characteristics | No. | % |
|---|---|---|
| Age group | ||
| <20 | 36 | 29.3 |
| 20-39 | 54 | 43.9 |
| 40-59 | 24 | 19.5 |
| ≥60 | 9 | 7.3 |
| Sex | ||
| Male | 52 | 42.3 |
| Female | 71 | 57.7 |
| International travel | 23 | 18.7 |
| COVID-19 vaccination statusa | ||
| Unvaccinated | 67 | 54.5 |
| Partially vaccinatedb | 7 | 5.7 |
| Vaccinated | 46 | 37.4 |
| Symptom profile | ||
| Asymptomatic | 30 | 24.4 |
| Symptomatic | 93 | 75.6 |
| Initial signs or symptoms | ||
| Fever | 40 | 32.5 |
| Chills | 19 | 15.4 |
| Cough | 36 | 29.3 |
| Sputum | 17 | 13.8 |
| Sore throat | 38 | 30.9 |
| Headache | 25 | 20.3 |
| Myalgia | 17 | 13.8 |
| Anosmia/Ageusia | 1 | 0.8 |
| Outcome | ||
| Severe Disease | - | |
| Death | - | |
a Vaccination history except unconfirmed 3 person.
b A partially vaccinated person had received a COVID-19 vaccine but not completed the primary series ≥14 days before illness onset or receipt of a positive SARS-CoV-2 test result.
| Characteristics | No. | % |
|---|---|---|
| Age group | ||
| <20 | 36 | 29.3 |
| 20-39 | 54 | 43.9 |
| 40-59 | 24 | 19.5 |
| ≥60 | 9 | 7.3 |
| Sex | ||
| Male | 52 | 42.3 |
| Female | 71 | 57.7 |
| International travel | 23 | 18.7 |
| COVID-19 vaccination statusa | ||
| Unvaccinated | 67 | 54.5 |
| Partially vaccinatedb | 7 | 5.7 |
| Vaccinated | 46 | 37.4 |
| Symptom profile | ||
| Asymptomatic | 30 | 24.4 |
| Symptomatic | 93 | 75.6 |
| Initial signs or symptoms | ||
| Fever | 40 | 32.5 |
| Chills | 19 | 15.4 |
| Cough | 36 | 29.3 |
| Sputum | 17 | 13.8 |
| Sore throat | 38 | 30.9 |
| Headache | 25 | 20.3 |
| Myalgia | 17 | 13.8 |
| Anosmia/Ageusia | 1 | 0.8 |
| Outcome | ||
| Severe Disease | - | |
| Death | - | |
a Vaccination history except unconfirmed 3 person.
b A partially vaccinated person had received a COVID-19 vaccine but not completed the primary series ≥14 days before illness onset or receipt of a positive SARS-CoV-2 test result.
Hyun-Kyung Kim, Boyeong Ryu, Min-Gyu Yoo, Jaehoon Kim, Kyung-Duk Min
Public Health Weekly Report 2025; 18(34): 1261-1276 https://doi.org/10.56786/PHWR.2025.18.34.1Chloe Jeongjin Lee, Yeonsu Kim, Gangju Lee, Kiryong Nam, Benimana Dieudonne Theos, Seungpil Jung, Woojoo Lee, Juhwan Oh, Seung-sik Hwang, Dasol Kim
Public Health Weekly Report 2024; 17(30): 1267-1284 https://doi.org/10.56786/PHWR.2024.17.30.1Ji-Ae Lim, Daehui Han, Dongkwon Choi, Yoo Ho Choi, Seung-Hee Jeong, Sang Ouk Woo, Oh-Hyun Cho
Public Health Weekly Report 2024; 17(22): 946-961 https://doi.org/10.56786/PHWR.2024.17.22.2